Explore a conference talk from ICAAC 2013 discussing the potential of human interferon alpha-n3 in combating oseltamivir-resistant H7N9 influenza. Learn about the April 2013 avian influenza A (H7N9) outbreak, its severity, and the development of drug resistance. Discover how this human interferon, already used for treating genital warts, shows promise against the virus. Delve into topics such as hemagglutinin, neuraminidase resistance, and the role of chickens in transmission. Understand the implications of this research, including interferon administration methods, potential for viral resistance, and the continued importance of flu vaccinations. Gain insights from experts Michael Schmidt and William M. Mitchell as they discuss the findings and answer audience questions about clinical trials and recombinant interferons.
Overview
Syllabus
Intro
What is Human Interferon
What is H7N9
What makes H7N9 dangerous
Hemagglutinin
Red air waves
neuraminidase resistance
Chickens
Headline News
The Good News
The Point of the Exercise
Interferon in Pig Cells
How do you administer interferon
Will the influenza virus become resistant to interferon
Should I still get a flu vaccine
Vaccination process continues
CDC recommends everyone get a vaccine
Audience Question
Is it in clinical trials
Is it recombinant
Conclusion
Taught by
American Society for Microbiology
